Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 12Phase 1/2 6Phase EARLY_PHASE1 5Phase 1 5Phase 4 2Phase 3 2

Status

Unknown 5Completed 5Active not recruiting 5Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 61Lymphoid 46Other hematologic neoplasm 28Plasma cell 26Thoracic 23Breast 23Genitourinary 22Other solid neoplasm 19CNS 18Gynecologic 16Tumor-Agnostic 15Head & Neck 14Endocrine 10Sarcoma 9Dermatologic 6NET 5Myeloid 3Other 2Other neoplasm 1

Conditions

Neuroendocrine Tumors 4Lung Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

lanreotide 1gallium Ga 68 dotatate 1Metformin 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × NET × Clear all
NCT05359146 2024-04-19

Beta plus

University Hospital, Basel, Switzerland

Phase EARLY_PHASE1 Unknown
16 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT04897542 2023-09-18

Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02817945 2022-04-07

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNETThoracic

Lung Neoplasms, Neuroendocrine Tumors

NCT02823691 2021-06-07

MetNET-2

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase EARLY_PHASE1 Unknown
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04041882 2019-08-01

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡